• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthGoogle Health

Google Health chief leaves to become CEO of health tech company Cerner

Jeremy Kahn
By
Jeremy Kahn
Jeremy Kahn
Editor, AI
Down Arrow Button Icon
Jeremy Kahn
By
Jeremy Kahn
Jeremy Kahn
Editor, AI
Down Arrow Button Icon
August 20, 2021, 6:47 AM ET
David Feinberg photo
David Feinberg, who had been leading Google’s health division, has been hired as CEO of Cerner, which makes electronic health records software. His departure from Google may mean the tech giant is rethinking its approach to the health care market.Michael Kovac—Getty Images

David Feinberg, the executive who has led Google’s health division, is leaving to become chief executive officer of electronic medical records provider Cerner.

Cerner announced Feinberg’s hiring in a press release last night.

Feinberg, who held the rank of a vice president at Google, was hired with great fanfare in 2018 to head the tech company’s newly formed Google Health arm. The division was supposed to consolidate multiple efforts to break into the health care market and to provide health care–related technology—initiatives already underway in different areas of the company.

For instance, the health care wing of DeepMind, the London-based A.I. firm owned by Google parent Alphabet had merged with Google Health. DeepMind had been working on using A.I. to read and make diagnoses from eye scans and other kinds of medical imagery as well as an app to alert doctors when patients in the hospital were at risk of developing acute kidney injury.

Feinberg’s departure may signal that the technology giant is rethinking its approach to health care products and services.

“Google deeply believes in the power of technology to improve health and wellness, and we have increased our health investments across the company,” Google said in a statement. “We are grateful for David’s leadership and guidance over the past few years to help accelerate our health efforts and wish him the best.”

The company did not immediately announce a successor for Feinberg. The Google Health division has more than 500 employees, and Feinberg reported to Jeff Dean, the senior vice president in charge of the company’s A.I. research and development, according to a February 2020 CNBC report.

Google Health struggled to make a major splash in the health care industry during Feinberg’s tenure. The company helped build contact tracing software for the COVID-19 pandemic alongside its erstwhile rival Apple, but that software has been less effective than hoped in helping to check the pandemic’s still churning waves of infection. Feinberg worked with Google’s YouTube to ensure that it provided more accurate information for doctors and other caregivers. And over the past year Google Health has expanded a software product called Care Studio, built in partnership with private U.S. hospital company Ascension, that helps doctors better navigate electronic medical records.

At Cerner, Feinberg will lead one of the world’s largest providers of electronic health records software. He succeeds Brent Shafer, who announced he was stepping down in May. Cerner said in announcing Feinberg’s appointment that Donald Trigg, its current president, would also be departing immediately.

Prior to joining Google, Feinberg, who is a medical doctor and also holds an MBA, had led the health care provider Geisinger, where he made the company a national leader in the savvy use of data analytics to improve patient outcomes and efficiency. Before that, he served as CEO of UCLA’s medical system.

More tech coverage from Fortune:

  • Apple accepts 15 Black- and brown-led businesses for impact accelerator
  • What are stablecoins? Your guide to the fast-rising alternative to Bitcoin and Ethereum
  • Employees may need to keep up “the pretense of working” as automation spreads, says A.I. expert Kai-Fu Lee
  • What will the future of Big Tech regulation look like? Europe offers some clues
  • A road trip on a single charge? Why the long-distance EV remains a pipe dream



Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Author
Jeremy Kahn
By Jeremy KahnEditor, AI
LinkedIn iconTwitter icon

Jeremy Kahn is the AI editor at Fortune, spearheading the publication's coverage of artificial intelligence. He also co-authors Eye on AI, Fortune’s flagship AI newsletter.

See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

HealthHealth
Confronting Asia’s growing rate of chronic conditions means tackling cultural issues as much as medical ones
By Stuart A. SpencerFebruary 15, 2026
1 day ago
Susan Blumenthal
AICancer
Meet the American spies who helped mammograms save more lives
By Erik GermanFebruary 15, 2026
2 days ago
HealthDietary Supplements
5 Best Nootropics of 2026: Expert Reviewed Supplements
By Christina SnyderFebruary 13, 2026
4 days ago
Big TechGen Z
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
4 days ago
Leesa Sapira Chill
Healthmattresses
Presidents Day Mattress Sales 2026: Find Deals on the Best Sleep Brands
By Christina SnyderFebruary 13, 2026
4 days ago
dog
CommentaryAnimals
You love your dog too much. Blame the broken American Dream and loss of purpose since the pandemic
By Margret Grebowicz and The ConversationFebruary 13, 2026
4 days ago

Most Popular

placeholder alt text
Economy
Social Security's trust fund is nearing insolvency, and the borrowing binge that may follow will rip through debt markets, economist warns
By Jason MaFebruary 15, 2026
1 day ago
placeholder alt text
Future of Work
Malcolm Gladwell tells young people if they want a STEM degree, 'don’t go to Harvard.' You may end up at the bottom of your class and drop out
By Sasha RogelbergFebruary 14, 2026
3 days ago
placeholder alt text
Real Estate
A billionaire and an A-list actor found refuge in a 37-home Florida neighborhood with armed guards—proof that privacy is now the ultimate luxury
By Marco Quiroz-GutierrezFebruary 15, 2026
2 days ago
placeholder alt text
Success
Meet the grandmother living out of a 400-ft ‘granny pod’ to save money and help with child care—it’s become an American ‘economic necessity’
By Emma BurleighFebruary 15, 2026
2 days ago
placeholder alt text
C-Suite
Blackstone mogul warned of 'urgent need' for AI preparedness—Now he’s turning his $48 billion fortune into a top philanthropic foundation
By Sydney LakeFebruary 16, 2026
23 hours ago
placeholder alt text
Commentary
Something big is happening in AI — and most people will be blindsided
By Matt ShumerFebruary 11, 2026
6 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.